Gen9, Inc. — Form D

Gen9, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-09-09. The offering totals $9.6M, of which $1.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Joseph JacobsonExecutive OfficerSan Jose, CA
Paul ManningDirectorCharlottesville, VA
George ChurchDirectorAustin, TX
George ChurchPromoterAustin, TX
Aaron ZuckerExecutive OfficerGlendale, CA
David StoneExecutive OfficerNew York, NY
Stanley RoseDirectorMansfield, MA
Jeremy WertheimerDirectorCAMBRIDGE, MA
Joseph JacobsonDirectorSan Jose, CA
Joseph JacobsonPromoterSan Jose, CA
Weili DaiDirectorLas Vegas, NV
Jennifer CamachoExecutive OfficerCambridge, MA
Jacob ThaysenDirectorCambridge, MA
Kevin MunnellyDirectorCambridge, MA
Kevin MunnellyExecutive OfficerCambridge, MA
James HollenhorstDirectorCambridge, MA
Drew EndyDirectorCambridge, MA
Drew EndyPromoterCambridge, MA
Neil CookDirectorCambridge, MA
Stephen JurvetsonDirectorMenlo Park, CA
Jim HollenhorstDirectorSanta Clara, CA
Bill ScalzulliDirectorCambridge, MA
Scott SchoenDirectorWeston, MA
Lawrence SilversteinExecutive OfficerBoston, MA
Martin GoldbergExecutive OfficerCambridge, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2014-07-30D$25.0M$25.0M
2013-05-07D$21.0M$21.0M
2012-05-22D$2.0M$395K
2011-04-28D/A$2.5M$2.0M
2011-02-10D$2.0M$1.7M
2009-06-15D$2.0M$500K

More